- Home
- ARBB vs CLDI Comparison
ARBB vs CLDI Comparison
Compare ARBB & CLDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARBB
- CLDI
- Stock Information
- Founded
- ARBB 1997
- CLDI 2014
- Country
- ARBB Singapore
- CLDI United States
- Employees
- ARBB N/A
- CLDI N/A
- Industry
- ARBB EDP Services
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ARBB Technology
- CLDI Health Care
- Exchange
- ARBB Nasdaq
- CLDI Nasdaq
- Market Cap
- ARBB 11.9M
- CLDI 10.2M
- IPO Year
- ARBB 2023
- CLDI N/A
- Fundamental
- Price
- ARBB $5.25
- CLDI $0.71
- Analyst Decision
- ARBB Strong Buy
- CLDI
- Analyst Count
- ARBB 1
- CLDI 0
- Target Price
- ARBB $20.00
- CLDI N/A
- AVG Volume (30 Days)
- ARBB 10.6K
- CLDI 41.7M
- Earning Date
- ARBB 08-01-2025
- CLDI 08-12-2025
- Dividend Yield
- ARBB N/A
- CLDI N/A
- EPS Growth
- ARBB N/A
- CLDI N/A
- EPS
- ARBB N/A
- CLDI N/A
- Revenue
- ARBB $24,425,491.00
- CLDI N/A
- Revenue This Year
- ARBB N/A
- CLDI N/A
- Revenue Next Year
- ARBB N/A
- CLDI N/A
- P/E Ratio
- ARBB N/A
- CLDI N/A
- Revenue Growth
- ARBB N/A
- CLDI N/A
- 52 Week Low
- ARBB $3.22
- CLDI $0.20
- 52 Week High
- ARBB $18.60
- CLDI $3.89
- Technical
- Relative Strength Index (RSI)
- ARBB 30.41
- CLDI 61.65
- Support Level
- ARBB $5.55
- CLDI $0.47
- Resistance Level
- ARBB $5.93
- CLDI $0.76
- Average True Range (ATR)
- ARBB 0.29
- CLDI 0.18
- MACD
- ARBB 0.01
- CLDI 0.02
- Stochastic Oscillator
- ARBB 0.87
- CLDI 34.56
About ARBB ARB IOT Group Limited
ARB IOT Group Ltd is engaged in provision of hardware and software of Internet of Things Solutions to meet customers' demand in four business lines, which are IoT Smart Home and Buildings, IoT Smart Agriculture, IoT System Development, and IoT Gadget Distribution. The company delivers holistic solutions with full turnkey deployment from designing, installation, testing, pre-commissioning, and commissioning of various IoT systems and devices as well as integration of automated systems, including installation of wire and wireless and mechatronic works. The company has two operating segments: Internet of Things ('IoT'), Investment holding and others. It earns its maximum profit from the Internet of Things (IoT) segment.
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.